Pathogen Safety Data Sheets: Infectious Substances – Rickettsia prowazekii
PATHOGEN SAFETY DATA SHEET - INFECTIOUS SUBSTANCES
SECTION I - INFECTIOUS AGENT
NAME: Rickettsia prowazekii
SYNONYM OR CROSS REFERENCE: Louse-borne typhus fever, Louse-borne epidemic typhus, LBET, Epidemic typhus, exanthematic typhus, historical typhus, classic typhus, sylvatic typhus, red louse disease, jail fever, Brill Zinsser disease
CHARACTERISTICS: Rickettsia prowazekii is an obligate intracellular bacterium of the Rickettsiacae familyFootnote 1Footnote 2. It is a small, gram-negative α-proteobacteria and is a coccobacillusFootnote 3.
SECTION II – HAZARD IDENTIFICATION
PATHOGENICITY/TOXICITY: Epidemic typhus is usually characterized by 1-3 days of malaise before abrupt onset of severe headaches and fever (40 ºC)Footnote 1Footnote 4. Symptoms include myalgia, arthralgia, abdominal pain, anorexia, chills, trachypnea, diarrhoea, myocarditis and tachycardiaFootnote 1Footnote 4. In 20-40% of cases, non-confluent erythematous rashes start in the axilla and then spread to the rest of the body with the exception of the face, palms of hands and soles of feetFootnote 5. Up to 80% of cases have CNS complications such as delirium, seizures, coma, meningeal irritation, confusion, drowsiness, and hearing lossFootnote 1. Cough has been reported in 38- 70% of cases and gangrene and necrosis of fingers and toes have occurredFootnote 1. The disease usually lasts for two weeks, although it may take months to fully recuperateFootnote 3. The mortality rate is estimated at 4% if the patient is treated with the appropriate antibiotics but the mortality rate is higher in individuals who are over the age of 60Footnote 1. A milder recurrent form of typhus called Brill Zinsser disease may occur in a patient that has previously had epidemic typhus and this form has a mortality rate of 1%Footnote 1Footnote 6.
EPIDEMIOLOGY: The disease is found in areas with cold weather, homelessness and poverty(1). It is a particular problem during famine, conflict and natural catastrophes as cramped conditions and lack of hygiene facilitate the spread of body liceFootnote 2. In the past 25 years, cases have been reported in Africa (Ethiopia, Nigeria and Burundi), Mexico, Central America, South America, Eastern Europe, Afghanistan, Northern India, China and the United StatesFootnote 2Footnote 6. Since 1976, 39 cases of epidemic typhus were reported in the United States and at least one third of the cases were related to contact with flying squirrelsFootnote 6.
HOST RANGE: Humans, flying squirrels (Glaucomys volans ) and body and head lice have been shown to contain the infectious agent in their tissuesFootnote 1. Livestock and donkeys have also been found to have Rickettsia prowazekii antibodies in their systemsFootnote 1.
INFECTIOUS DOSE: The median infectious dose for epidemic typhus is < 10 rickettsial particlesFootnote 7.
MODE OF TRANSMISSION: The infection is caused by the contamination of a louse bite site, superficial abrasion, conjunctivae or mucous membranes with louse feces or crushed louse tissuesFootnote 1Footnote 8. The disease can also be transmitted by inhalation of infectious aerosols (like louse fecal dust), which poses a potential risk for healthcare workers and laboratory personnelFootnote 2Footnote 8. The body louse is infected when feeding on an infected human and the flying squirrel may be infected by fleas and liceFootnote 1.
COMMUNICABILITY: Although human-to-human transmission does not occur, proximity to an infected individual increases the chances of exposure to infected body lice(1). Humans remain infective for life and can pass the disease to liceFootnote 2. The lice tend to leave sick individuals and go towards healthier hosts(1). Lice become infective 5-7 days after exposure and remain so for life; however, they tend to die 1 week after contracting the bacteriaFootnote 1Footnote 3Footnote 9. The lice feces remain infective for 100 days as aerosols and this is the proposed mode of transmission between flying squirrels and humansFootnote 1Footnote 3.
SECTION III - DISSEMINATION
RESERVOIR: Humans are necessary to maintain the infection; however, flying squirrels may also be a potential reservoir for the disease(1).
ZOONOSIS: The flying squirrel may spread the disease to humans indirectly via infected lice or infective lice feces in aerosol formFootnote 1.
VECTORS: The body louse, Pediculus humanis corporis is the main vector for epidemic typhus although it has been proposed that head lice, Pediculus humanis capitis , could also be a vectorFootnote 1Footnote 10.
SECTION IV – STABILITY AND VIABILITY
DRUG SUSCEPTIBILITY: The infectious agent is susceptible to tetracyclines, chloramphenicol, or doxycycline. Therapy with doxycycline for 5-7 days, or 2-4 days after defervescence, is recommended to preclude relapses. In outbreak situations, a single oral dose of doxyxycline can be givenFootnote 1Footnote 2Footnote 3.
SUSCEPTIBILITY TO DISINFECTANTS: Gram-negative bacteria are susceptible to 1% sodium hypochlorite, 4% formaldehyde, 2% glutaraldehyde, 70% ethanol, 2% peracetic acid, 3- 6% hydrogen peroxide and 0.16% iodineFootnote 8.
PHYSICAL INACTIVATION: Rickettsia prowazekii is susceptible to moist heat (121 ºC for at least 15 minutes) and dry heat (170 ºC for at least 1 hour)Footnote 11.
SECTION V – FIRST AID / MEDICAL
SURVEILLANCE: Monitor for symptomsFootnote 12. The infection can be identified by PCR, latex agglutination test, or immunological tests (i.e. enzyme-linked immunoabsorbent, immunoperoxidase, dot blot, Western blotting, and IFA assays, CF and latex agglutination tests)Footnote 1Footnote 3Footnote 4Footnote 13. Microbiological diagnosis is usually based on serology, where a four-fold rise in titre in paired samples is considered diagnostic. The organism can be isolated following culture of clinical samples (blood or skin biopsy) and visualized using microscopy following Gimenez staining or immunofluorescenceFootnote 1.
Note: All diagnostic methods are not necessarily available in all countries.
FIRST AID/TREATMENT: If typhus is suspected, the appropriate antibiotic treatment should be given without waiting for laboratory confirmationFootnote 12.
IMMUNIZATION: No vaccine is currently commercially available; however, some experimental vaccines are being developed for high-risk individuals (such as healthcare workers and scientists)Footnote 1Footnote 3Footnote 4Footnote 8.
PROPHYLAXIS: If louse infestation is present, clothes should be removed, washed and not worn for 7 days. Insecticides (i.e. malathion or permethrine) should be used on body and hair to kill louse eggs but can also be used on clothesFootnote 1.
SECTION VI - LABORATORY HAZARDS
LABORATORY-ACQUIRED INFECTIONS: 56 laboratory-acquired infections with 3 deaths caused by epidemic typhus have been reported although all of these are prior to 1968Footnote 8Footnote 12. There were 57 cases additional of unidentified typhus within that same period of timeFootnote 12.
SOURCES/SPECIMENS: Infective lice, their tissues and their feces may contain the infective agentFootnote 12. Flying squirrels may also be a direct source of infection.
PRIMARY HAZARDS: The primary hazards are accidental parenteral inoculation and exposure to infectious aerosols or animalsFootnote 12.
SPECIAL HAZARDS: None
SECTION VII – EXPOSURE CONTROLS / PERSONAL PROTECTION
RISK GROUP CLASSIFICATION: Risk group 3Footnote 14.
CONTAINMENT REQUIREMENTS: Containment Level 3 facilities, equipment, and operational practices for work involving infected or potentially infected materials, animals, or cultures.
PROTECTIVE CLOTHING: Personnel entering the laboratory should remove street clothing and jewellery, and change into dedicated laboratory clothing and shoes, or don full coverage protective clothing (i.e., completely covering all street clothing). Additional protection may be worn over laboratory clothing when infectious materials are directly handled, such as solid-front gowns with tight fitting wrists, gloves, and respiratory protection. Eye protection must be used where there is a known or potential risk of exposure to splashesFootnote 15.
OTHER PRECAUTIONS: All activities with infectious material should be conducted in a biological safety cabinet (BSC) or other appropriate primary containment device in combination with personal protective equipment. Centrifugation of infected materials must be carried out in closed containers placed in sealed safety cups, or in rotors that are loaded or unloaded in a biological safety cabinet. The use of needles, syringes, and other sharp objects should be strictly limited. Open wounds, cuts, scratches, and grazes should be covered with waterproof dressings. Additional precautions should be considered with work involving animals or large scale activitiesFootnote 15.
SECTION VIII - HANDLING AND STORAGE
SPILLS: Allow aerosols to settle and, wearing protective clothing, gently cover spill with paper towels and apply appropriate disinfectant, starting at the perimeter and working towards the centre. Allow sufficient contact time before clean up (30 min)Footnote 15.
DISPOSAL: Decontaminate all materials before disposal by steam sterilization or incinerationFootnote 15.
STORAGE: The infectious agent should be stored in a sealed and identified container in a level 3 containment laboratoryFootnote 15.
SECTION IX – REGULATORY AND OTHER INFORMATION
REGULATORY INFORMATION: The import, transport, and use of pathogens in Canada is regulated under many regulatory bodies, including the Public Health Agency of Canada, Health Canada, Canadian Food Inspection Agency, Environment Canada, and Transport Canada. Users are responsible for ensuring they are compliant with all relevant acts, regulations, guidelines, and standards.
UPDATED: July 2010
PREPARED BY: Pathogen Regulation Directorate, Public Health Agency of Canada.
Although the information, opinions and recommendations contained in this Pathogen Safety Data Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date.
Public Health Agency of Canada, 2010
- Footnote 1
Bechah, Y., Capo, C., Mege, J. L., & Raoult, D. (2008). Epidemic typhus. The Lancet Infectious Diseases, 8 (7), 417-426. doi:10.1016/S1473-3099(08)70150-6
- Footnote 2
Parola, P., & Raoult, D. (2006). Tropical rickettsioses. Clinics in Dermatology, 24 (3), 191-200. doi:10.1016/j.clindermatol.2005.11.007
- Footnote 3
Bronze, M.S., and Greenfield, R.A (Ed.). (2005). Biodefence Principles and Pathogens horizon bioscience.
- Footnote 4
Krauss, H., Weber, A., Appel, M., Enders, B., Isenberg, H. D., Schiefer, H. G., Slenczka, W., von Graevenitz, A., & Zahner, H. (Eds.). (2003). Zoonoses Infectious Diseases Transmissible from Animals to Humans (3rd ed.). Washington: ASM press.
- Footnote 5
Brock, T. D., Madigan, M. T., Martinko, J. M., & Parker, J. (2000). Biology of Microorganisms (9th ed.). New Jersey, USA: Prentice-Hall, Inc.
- Footnote 6
Gillespie, J. J., Ammerman, N. C., Beier-Sexton, M., Sobral, B. S., & Azad, A. F. (2009). Louse- and flea-borne rickettsioses: biological and genomic analyses. Veterinary Research, 40 (2), 12. doi:10.1051/vetres:2008050
- Footnote 7
Azad, A. F. (2007). Pathogenic rickettsiae as bioterrorism agents. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 45 Suppl 1 , S52-5. doi:10.1086/518147
- Footnote 8
Collins, C. H., & Kennedy, D. A. (1999). Laboratory acquired infections. Laboratory acquired infections: History, incidence, causes and prevention (4th ed., pp. 1-37). Woburn, MA: BH.
- Footnote 9
Murray, P. R., Baron, E. J., Jorgensen, J. H., Landry, M. L., & Pfaller, M. A. (Eds.). (2007). Manual of Clinical Microbiology (9th ed.). Washington: ASM Press.
- Footnote 10
Robinson, D., Leo, N., Prociv, P., & Barker, S. C. (2003). Potential role of head lice, Pediculus humanus capitis, as vectors of Rickettsia prowazekii. Parasitology Research, 90 (3), 209-211. doi:10.1007/s00436-003-0842-5
- Footnote 11
Joslyn, L. J. (2001). Sterilization by Heat. In S. S. Block (Ed.), Disinfection, Sterilization, and Preservation (5th ed., pp. 695). Philadelphia: Lippincott Williams & Wilkins.
- Footnote 12
Richmond, J. Y., & McKinney, R. W. (Eds.). (2007). Biosafety in Microbiological and Biomedical Laboratories (BMBL) (5th ed.). Washington, D.C.: Centers for Disease Control and Prevention.
- Footnote 13
Fournier, P. E., Ndihokubwayo, J. B., Guidran, J., Kelly, P. J., & Raoult, D. (2002). Human pathogens in body and head lice. Emerging Infectious Diseases, 8 (12), 1515-1518.
- Footnote 14
Human pathogens and toxins act. S.C. 2009, c. 24, Second Session, Fortieth Parliament, 57- 58 Elizabeth II, 2009. (2009).
- Footnote 15
Public Health Agency of Canada. (2004). In Best M., Graham M. L., Leitner R., Ouellette M. and Ugwu K. (Eds.), Laboratory Biosafety Guidelines (3rd ed.). Canada: Public Health Agency of Canada.
Report a problem or mistake on this page
- Date modified: